Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018)

Akebia Therapeutics (AKBA) has disclosed Current Taxes for 2 consecutive years, with $987000.0 as the latest value for Q1 2018.

  • On a quarterly basis, Current Taxes changed N/A to $987000.0 in Q1 2018 year-over-year; TTM through Mar 2018 was $987000.0, a N/A change, with the full-year FY2017 number at $987000.0, changed N/A from a year prior.
  • Current Taxes was $987000.0 for Q1 2018 at Akebia Therapeutics, roughly flat from $987000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $987000.0 in Q4 2017 to a low of $987000.0 in Q4 2017.